Hepion Pharmaceuticals, Inc. (HEPA) analyst actions
Rating and price-target actions on HEPA in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the HEPA overview →
1 measured HEPA analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial | Press release | +9.01% | +15.57% |
Keep exploring
More HEPA: earnings → · SEC filings → · HEPA overview →